Trying to separate three different claims about collagen peptides: that it is the right molecule, that it is the right dose, and that it does something useful.
If you need three other compounds to notice the first one, you have not tested the first one.
My rule now: if a claim cannot survive being written down with the numbers attached, it is marketing.
The interesting question is not whether it works but for whom and at what cost.
How long before you can reasonably say something is or is not doing anything? Tolerance was my main issue with collagen peptides too.
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison.
Loose evidence and no evidence are different, and people overcorrect in both directions.
My rule, after years of this: if it cannot survive being written down with the numbers attached, it is marketing.
Baseline first. Without a baseline the after picture is decoration.
Read the methods section. It is the only part that says whether the conclusion is allowed to exist.
Is a baseline blood test really necessary before starting something like this? Tolerance was my main issue with collagen peptides too.
Read methods.
Three questions kill most of the confidence in a thread like this: sample size, blinding, who paid.
What is the first thing you would read if you were starting from zero?